FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jordi Fontcuberta

Research Profile

Disorders

Geographic Areas

Spain

Concepts & Ideas

Anatomy

Thrombosis

Physiology

Genes & Molecular Sequences

Chemicals & Drugs

Procedures

Case Control Studies

Living Beings

Infants

Co-author Network

Publications

TOP 3
Mercedes Camacho; Jordi Fontcuberta; Sonia López; Angel Martinez-Perez; Laura Siguero; Sonia Alcolea; Alfonso Buil; Juan-Carlos Souto; Luis Vila; José-Manuel Soria
Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular risk.
Silvia Navarro; José M Ricart; José Todolí; Amparo Vayá; Amparo Estellés; Jordi Fontcuberta; Laura Martos; Pilar Medina; Elena Bonet; Francisco España
Haplotypes of the endothelial protein C receptor gene and Behçet's disease.
María Eugenia de la Morena-Barrio; Jordi Fontcuberta; María Fernanda López; Irene Martínez-Martínez; Antonia Miñano; José Navarro-Fernández; José Padilla; Vicente Vicente; Sonia Águila; Ana Isabel Antón; Javier Corral
Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jordi Fontcuberta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Mercedes Camacho; Jordi Fontcuberta; Sonia López; Angel Martinez-Perez; Laura Siguero; Sonia Alcolea; Alfonso Buil; Juan-Carlos Souto; Luis Vila; José-Manuel Soria
Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular risk.
Atherosclerosis 2012;224(1):129-35.
2012: Silvia Navarro; José M Ricart; José Todolí; Amparo Vayá; Amparo Estellés; Jordi Fontcuberta; Laura Martos; Pilar Medina; Elena Bonet; Francisco España
Haplotypes of the endothelial protein C receptor gene and Behçet's disease.
Thrombosis research 2012;129(4):459-64.
2012: María Eugenia de la Morena-Barrio; Jordi Fontcuberta; María Fernanda López; Irene Martínez-Martínez; Antonia Miñano; José Navarro-Fernández; José Padilla; Vicente Vicente; Sonia Águila; Ana Isabel Antón; Javier Corral
Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency.
Thrombosis and haemostasis 2012;107(3):430-7.
2012: Sonia López; Angel Martinez-Perez; Juan Carlos Souto; Laura A Almasy; John C Blangero; Alfonso Buil; Jordi Casademont; Jordi Fontcuberta; Mark Lathrop; Jose Manuel Soria
Sex-specific regulation of mitochondrial DNA levels: genome-wide linkage analysis to identify quantitative trait loci.
PloS one 2012;7(8):e42711.
2012: María Concepción García-Dabrio; Angel Martinez-Perez; Núria Pujol-Moix; José Manuel Soria; Joan Carles Souto; Jordi Fontcuberta; Josep F Nomdedéu
Influence of age, gender and lifestyle in lymphocyte subsets: report from the Spanish Gait-2 Study.
Acta haematologica 2012;127(4):244-9.
2011: Salvador Rico; Rosa Maria Antonijoan; Ignasi Gich; Montserrat Borrell; Jordi Fontcuberta; Manuel Monreal; Javier Martinez-Gonzalez; Manel J Barbanoj
Safety assessment and pharmacodynamics of a novel ultra low molecular weight heparin (RO-14) in healthy volunteers--a first-time-in-human single ascending dose study.
Thrombosis research 2011;127(4):292-8.
2011: Jose Mateo; Victoria Moral; Pilar Paniagua; Tobias Koller; Jordi Fontcuberta
Dextran and hydroxyethyl starch do not interfere with fibrinogen measurement if Clauss method with mechanical clot detection is used.
Critical care (London, England) 2011;15(5):441.
2010: Joan Martí-Fàbregas; Montserrat Borrell; Yolanda Silva; Raquel Delgado-Mederos; Sergi Martínez-Ramírez; M de Juan Delago; Isabel Tirado; Aída Alejaldre; Rebeca Marín; Josep-Lluis Martí-Vilalta; Jordi Fontcuberta
Hemostatic proteins and their association with hematoma growth in patients with acute intracerebral hemorrhage.
Stroke; a journal of cerebral circulation 2010;41(12):2976-8.
2010: Alfonso Buil; David-Alexandre Trégouët; Juan Carlos Souto; Noémie Saut; Marine Germain; Maxime Rotival; Laurence Tiret; Françcois Cambien; Mark Lathrop; Tanja Zeller; Marie-Christine Alessi; Santiago Rodriguez de Cordoba; Thomas Münzel; Philipp Wild; Jordi Fontcuberta; France Gagnon; Joseph Emmerich; Laura A Almasy; Stefan Blankenberg; José Manuel Soria; Pierre Morange
C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies.
Blood 2010;115(23):4644-50.
2010: Francesc Calafell; Laura A Almasy; Maria Sabater-Lleal; Alfonso Buil; Carolina Mordillo; Anna Ramírez-Soriano; Martin Sikora; Juan Carlos Souto; John C Blangero; Jordi Fontcuberta; José Manuel Soria
Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels.
Human molecular genetics 2010;19(3):517-25.
2010: Maria Sabater-Lleal; Miguel Chillón; Carolina Mordillo; Angel Martínez; Estel Gil; José Mateo; John C Blangero; Laura A Almasy; Jordi Fontcuberta; José Manuel Soria
Combined cis-regulator elements as important mechanism affecting FXII plasma levels.
Thrombosis research 2010;125(2):e55-60.
2010: Luis Vila; Angel Martinez-Perez; Mercedes Camacho; Alfonso Buil; Sonia Alcolea; Nuria Pujol-Moix; Marta Soler; Rosa Antón; Juan-Carlos Souto; Jordi Fontcuberta; José-Manuel Soria
Heritability of thromboxane A2 and prostaglandin E2 biosynthetic machinery in a Spanish population.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(1):128-34.
2009: José Manuel Soria; Laura A Almasy; Juan Carlos Souto; Maria Sabaterlleal; Jordi Fontcuberta; John C Blangero
The F7 gene and clotting factor VII levels: dissection of a human quantitative trait locus. 2005.
Human biology 2009;81(5-6):853-67.
2009: Rosa Antonijoan; S Rico; J Martínez-González; Montserrat Borrell; D Valcarcel; Jordi Fontcuberta; Manel J Barbanoj
Comparative pharmacodynamic time-course of bemiparin and enoxaparin in healthy volunteers.
International journal of clinical pharmacology and therapeutics 2009;47(12):726-32.
2009: Anders Mälarstig; Alfonso Buil; Juan Carolos Souto; Robert Clarke; Francisco Blanco-Vaca; Jordi Fontcuberta; John Peden; Malin Andersen; Angela Silveira; Simona Barlera; Udo Seedorf; Hugh Watkins; Laura A Almasy; Anders Hamsten; José Manuel Soria
Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study.
Blood 2009;114(7):1417-22.
2009: Vanessa Roldán; Adriana Ordoñez; Francisco Marín; Esther Zorio; José M Soria; Antonia Miñano; Francisco España; Rocio González-Conejero; Javier Pineda; Amparo Estellés; Jordi Fontcuberta; Vicente Vicente; Javier Corral
Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis.
Thrombosis and haemostasis 2009;101(3):483-6.
2009: José Manuel Soria; Silvia Navarro; Pilar Medina; Ramón Souto; Alfonso Buil; Amparo Estellés; Jordi Fontcuberta; Francisco España
Heritability of plasma concentrations of activated protein C in a Spanish population.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(1):17-21.
2008: Jordi Fontcuberta
[Oral anticoagulat treatment in venous thromboembolic disease].
Medicina clínica 2008;131 Suppl 2():60-5.
2008: Sonia López; Alfonso Buil; Jordi Ordoñez; Juan Carlos Souto; Laura A Almasy; Mark Lathrop; John C Blangero; Francisco Blanco-Vaca; Jordi Fontcuberta; José Manuel Soria
Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels.
European journal of human genetics : EJHG 2008;16(11):1372-9.
2008: Maria Sabater-Lleal; Alfonso Buil; Juan Carlos Souto; Laura Alamsy; Montserrat Borrell; Mark Lathrop; John C Blangero; Jordi Fontcuberta; José Manuel Soria
A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels.
Human genetics 2008;124(1):81-8.
2008: Montserrat Borrell; Isabel Tirado; José Mateo; Artur Oliver; Amparo Santamaría; Jordi Fontcuberta
IgM anti-protein S antibodies as a risk factor for venous thrombosis.
Haematologica 2008;93(7):1115-7.
2008: Antonia Miñano; Adriana Ordóñez; Francisco España; José Ramón González-Porras; Ramón Lecumberri; Jordi Fontcuberta; Pilar Llamas; Francisco Marín; Amparo Estellés; Ignacio Alberca; Vicente Vicente; Javier Corral
AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Haematologica 2008;93(5):729-34.
2008: José M Ricart; Luis Andrés Ramón Núñez; Amparo Vayá; Francisco España; Maria-Luisa Santaolaria; José Todolí; Remedios Castelló; Jordi Fontcuberta; Amparo Estellés
Fibrinolytic inhibitor levels and polymorphisms in Behçet disease and their association with thrombosis.
British journal of haematology 2008;141(5):716-9.
2008: Pere Barba; Amparo Santamaría; Isabel Tirado; Edelmira Martí; Jordi Fontcuberta
Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis.
Thrombosis and haemostasis 2008;99(2):443-4.
2008: Amparo Santamaría; Jordi Fontcuberta
[Anticoagulation therapy and pregnancy].
Medicina clínica 2008;130(2):57-9.
2008: Joan Martí-Fàbregas; Montserrat Borrell; Dolores Cocho; Sergi Martínez-Ramírez; Mercè Martínez-Corral; Jordi Fontcuberta; Josep-Lluis Martí-Vilalta
Change in hemostatic markers after recombinant tissue-type plasminogen activator is not associated with the chance of recanalization.
Stroke; a journal of cerebral circulation 2008;39(1):234-6.
2008: Rafael Otero-Fernández; Antonio Gómez-Outes; Javier Martínez-González; Eduardo Rocha; Jordi Fontcuberta
Evaluation of the effectiveness and safety of bemiparin in a large population of orthopedic patients in a normal clinical practice.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2008;14(1):75-83.
2007: José L Navarro; Jesús M Cesar; María A Fernández; Jordi Fontcuberta; Joan Carles Reverter; Jordi Gol-Freixa
[Morbidity and mortality in patients treated with oral anticoagulants].
Revista española de cardiología 2007;60(12):1226-32.
2007: Maria Sabater-Lleal; Miguel Chillón; Tom E Howard; Estel Gil; Laura A Almasy; John C Blangero; Jordi Fontcuberta; José Manuel Soria
Functional analysis of the genetic variability in the F7 gene promoter.
Atherosclerosis 2007;195(2):262-8.
2007: Carolina Mordillo; Elisabeth Martinez-Marchán; Jordi Fontcuberta; José Manuel Soria
Molecular analysis of multiple genetic variants in Spanish FXII-deficient families.
Haematologica 2007;92(11):1569-72.
2007: Amparo Santamaría; Arturo Oliver; Montserrat Borrell; Robert Belvís; Joan Martí-Fábregas; José Mateo; Jordi Fontcuberta
Higher risk of ischaemic stroke associated with factor XI levels in dyslipidaemic patients.
International journal of clinical practice 2007;61(11):1819-23.
2007: Robert Belvís; Amparo Santamaría; Joan Martí-Fàbregas; Rubén Leta; Dolores Cocho; Montserrat Borrell; Jordi Fontcuberta; Josep-Lluis Martí-Vilalta
Patent foramen ovale and prothrombotic markers in young stroke patients.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(6):537-42.
2007: Javier Corral; David Hernandez-Espinosa; Jose Manual Soria; Rocio Gonzalez-Conejero; Adriana Ordonez; Jose Ramon Gonzalez-Porras; Elena Perez-Ceballos; Ramón Lecumberri; Ignacio Sanchez; Vanessa Roldan; Jose Mateo; Antonia Minano; Marcos Gonzalez; Ignacio Alberca; Jordi Fontcuberta; Vicente Vicente
Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis.
Blood 2007;109(10):4258-63.
2007: Kevin R Viel; Deepa machiah; Diane M Warren; Manana Khachidze; Alfonso Buil; Karl Fernstrom; Juan Carlos Souto; Juan M Peralta; Todd Smith; John C Blangero; Sandra Porter; Stephen Warren; Jordi Fontcuberta; José Manuel Soria; W Dana Flanders; Laura A Almasy; Tom E Howard
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels.
Blood 2007;109(9):3713-24.
2007: Dolors Llobet; Montserrat Borrell; Ll Vila; Cristina Vallvé; Rosa Felices; Jordi Fontcuberta
An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient.
Haematologica 2007;92(2):e17-9.
2007: Angel F Remacha; Camino Estivill; M Pilar Sarda; José Mateo; Juan Carlos Souto; Carme Canals; Josep F Nomdedéu; Jordi Fontcuberta
The V617F mutation of JAK2 is very uncommon in patients with thrombosis.
Haematologica 2007;92(2):285-6.
2007: M Constans; Amparo Santamaria; José Mateo; N Pujol; Juan Carlos Souto; Jordi Fontcuberta
Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagulation in patients undergoing colonoscopy or gastroscopy.
International journal of clinical practice 2007;61(2):212-7.
2007: Mónica López; Pilar Giraldo; Patricia Alvarez; R Cornudella; Miguel Pocoví; Antonio Martínez; Jordi Fontcuberta; José Manuel Soria
Multiplex assay for genetic testing of thrombophilia: a method for routine clinical care.
Journal of clinical laboratory analysis 2007;21(6):349-55.
2007: Alexandre Perera; Alfonso Buil; Maria Chiara Di Bernardo; Maria Sabater-Lleal; Linda Pattini; Juan Carlos Souto; Jordi Fontcuberta; Montserrat Vallverdu; José Manuel Soria; Pere Caminal
Clustering of individuals given SNPs similarity based on normalized mutual information: F7 SNPs in the GAIT sample.
Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 2007;2007():123-6.
2006: Robert Belvís; Amparo Santamaría; Joan Martí-Fàbregas; Dolores Cocho; Montserrat Borrell; Jordi Fontcuberta; Josep-Lluis Martí-Vilalta
Diagnostic yield of prothrombotic state studies in cryptogenic stroke.
Acta neurologica Scandinavica 2006;114(4):250-3.
2006: Manana Khachidze; Alfonso Buil; K R Viel; S Porter; D Warren; Deepa machiah; José Manuel Soria; Juan Carlos Souto; Afshin Ameri; Mark Lathrop; John C Blangero; Jordi Fontcuberta; Stephen Warren; Laura A Almasy; Tom E Howard
Genetic determinants of normal variation in coagulation factor (F) IX levels: genome-wide scan and examination of the FIX structural gene.
Journal of thrombosis and haemostasis : JTH 2006;4(7):1537-45.
2006: Javier Corral; Rocio González-Conejero; Jose Manuel Soria; Jose Ramón González-Porras; Elena Pérez-Ceballos; Ramón Lecumberri; Vanessa Roldán; Juan Carlos Souto; Antonia Miñano; David Hernández-Espinosa; Ignacio Alberca; Jordi Fontcuberta; Vicente Vicente
A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis.
Blood 2006;108(1):177-83.
2006: Diane M Warren; Shelley A Cole; Thomas D Dyer; José Manuel Soria; Juan Carlos Souto; Jordi Fontcuberta; John C Blangero; Jean W MacCluer; Laura A Almasy
A locus on chromosome 13 influences levels of TAFI antigen in healthy Mexican Americans.
Human biology 2006;78(3):329-39.
2006: Amparo Santamaría; S Juárez; A Reche; Antonio Gómez-Outes; J Martínez-González; Jordi Fontcuberta
Low-molecular-weight heparin, bemiparin, in the outpatient treatment and secondary prophylaxis of venous thromboembolism in standard clinical practice: the ESFERA Study.
International journal of clinical practice 2006;60(5):518-25.
2006: Maria Sabater-Lleal; Laura A Almasy; Elisabeth Martínez-Marchán; Elisabeth Martínez-Sánchez; R Souto; John C Blangero; Juan Carlos Souto; Jordi Fontcuberta; José Manuel Soria
Genetic architecture of the F7 gene in a Spanish population: implication for mapping complex diseases and for functional assays.
Clinical genetics 2006;69(5):420-8.
2006: Dolores Cocho; Montserrat Borrell; Joan Martí-Fàbregas; Joan Montaner; Mar Castellanos; Yolanda Bravo; Laura Molina-Porcel; Robert Belvís; Jordi Díaz-Manera; Alejandro Martínez-Domeño; María Martínez-Lage; Mónica Millán; Jordi Fontcuberta; Josep-Lluis Martí-Vilalta
Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator.
Stroke; a journal of cerebral circulation 2006;37(4):996-9.
2006: José Mateo; Isabel Badell; Ruth Forner; Montserrat Borrell; Eduardo F Tizzano; Jordi Fontcuberta
Successful suppression using Rituximab of a factor VIII inhibitor in a boy with severe congenital haemophilia: an example of a significant decrease of treatment costs.
Thrombosis and haemostasis 2006;95(2):386-7.
2006: Maria Sabater-Lleal; José Manuel Soria; Jaume Bertranpetit; Laura A Almasy; John C Blangero; Jordi Fontcuberta; Francesc Calafell
Human F7 sequence is split into three deep clades that are related to FVII plasma levels.
Human genetics 2006;118(6):741-51.
2006: Angel F Remacha; Juan Carlos Souto; José Manuel Soria; Alfonso Buil; M Pilar Sardà; Mark Lathrop; John C Blangero; Laura A Almasy; Jordi Fontcuberta
Genomewide linkage analysis of soluble transferrin receptor plasma levels.
Annals of hematology 2006;85(1):25-8.
2005: José Manuel Soria; Laura A Almasy; Juan Carlos Souto; Maria Sabater-Lleal; Jordi Fontcuberta; John C Blangero
The F7 gene and clotting factor VII levels: dissection of a human quantitative trait locus.
Human biology 2005;77(5):561-75.
2005: Eduardo F Tizzano; María Jesús Barceló; Manel Baena; Mónica Cornet; Adoración Venceslá; José Mateo; Jordi Fontcuberta; Montserrat Baiget
Rapid identification of female haemophilia A carriers with deletions in the factor VIII gene by quantitative real-time PCR analysis.
Thrombosis and haemostasis 2005;94(3):661-4.
2005: José Manuel Soria; Jordi Fontcuberta
New approaches and future prospects for evaluating genetic risk of thrombosis.
Haematologica 2005;90(9):1212-22.
2005: Carla Y Vossen; Isobel D Walker; Peter Svensson; Juan C Souto; Inge Scharrer; F Eric Preston; Gualtiero Palareti; Ingrid Pabinger; Felix J M van der Meer; Mike Makris; Jordi Fontcuberta; Jacqueline Conard; Frits R Rosendaal
Recurrence rate after a first venous thrombosis in patients with familial thrombophilia.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(9):1992-7.
2005: Joan Martí-Fàbregas; Montserrat Borrell; Dolores Cocho; Robert Belvís; Mar Castellanos; J Montaner; Javier Pagonabarraga; Aitziber Aleu; Laura Molina-Porcel; Jordi Díaz-Manera; Yolanda Bravo; J Alvarez-Sabín; A Dávalos; Jordi Fontcuberta; Josep-Lluis Martí-Vilalta
Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA.
Neurology 2005;65(3):366-70.
2005: Laura A Almasy; José Manuel Soria; Juan Carlos Souto; Diane M Warren; Alfonso Buil; Montserrat Borrell; Xavier Muñoz; Núria Sala; Mark Lathrop; Jordi Fontcuberta; John C Blangero
A locus on chromosome 2 influences levels of tissue factor pathway inhibitor: results from the GAIT study.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(7):1489-92.
2005: Amparo Santamaría; José Manuel Soria; Isabel Tirado; José Mateo; Immaculada Coll; Juan Carlos Souto; Jordi Fontcuberta
Double heterozygosity for Factor V Leiden and Factor V Cambridge mutations associated with low levels of activated protein C resistance in a Spanish thrombophilic family.
Thrombosis and haemostasis 2005;93(6):1193-5.
2005: Juan Carlos Souto; Francisco Blanco-Vaca; José Manuel Soria; Alfonso Buil; Laura A Almasy; Jordi Ordoñez-Llanos; Jesús M Martín-Campos; Mark Lathrop; William Stone; John C Blangero; Jordi Fontcuberta
A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project.
American journal of human genetics 2005;76(6):925-33.
2005: José Manuel Soria; Laura A Almasy; Juan Carlos Souto; Alfonso Buil; Mark Lathrop; John C Blangero; Jordi Fontcuberta
A genome search for genetic determinants that influence plasma fibrinogen levels.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(6):1287-92.
2005: Carla Y Vossen; Jacqueline Conard; Jordi Fontcuberta; Mike Makris; Felix J M van der Meer; Ingrid Pabinger; Gualtiero Palareti; F Eric Preston; Inge Scharrer; Juan C Souto; Peter Svensson; Isobel D Walker; Frits R Rosendaal
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).
Journal of thrombosis and haemostasis : JTH 2005;3(3):459-64.
2005: Isabel Tirado; José Mateo; José Manuel Soria; Arturo Oliver; Elisabeth Martínez-Sánchez; Cristina Vallvé; Montserrat Borrell; Teresa Urrutia; Jordi Fontcuberta
The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism.
Thrombosis and haemostasis 2005;93(3):468-74.
2005: Diane M Warren; José Manuel Soria; Juan Carlos Souto; Anthony G Comuzzie; Jordi Fontcuberta; John C Blangero; Jean W MacCluer; Laura A Almasy
Heritability of hemostasis phenotypes and their correlation with type 2 diabetes status in Mexican Americans.
Human biology 2005;77(1):1-15.
2005: Bárbara Menéndez-Jándula; Juan Carlos Souto; Arturo Oliver; Isabel Montserrat; Mireia Quintana; Ignasi Gich; Xavier Bonfill; Jordi Fontcuberta
Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial.
Annals of internal medicine 2005;142(1):1-10.
2004: Carla Y Vossen; Jacqueline Conard; Jordi Fontcuberta; Mike Makris; Felix J M van der Meer; Ingrid Pabinger; Gualtiero Palareti; F Eric Preston; Inge Scharrer; Juan C Souto; Peter Svensson; Isobel D Walker; Frits R Rosendaal
Familial thrombophilia and lifetime risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2004;2(9):1526-32.
2004: Amparo Santamaría; Montserrat Borrell; Arturo Oliver; Rosa Ortín; Ruth Forner; Inmaculada Coll; José Mateo; Juan Carlos Souto; Jordi Fontcuberta
Association of functional thrombin-activatable fibrinolysis inhibitor (TAFI) with conventional cardiovascular risk factors and its correlation with other hemostatic factors in a Spanish population.
American journal of hematology 2004;76(4):348-52.
2004: Amparo Santamaría; José Mateo; Isabel Tirado; Arturo Oliver; Robert Belvís; Joan Martí-Fábregas; Rosa Felices; José Manuel Soria; Juan Carlos Souto; Jordi Fontcuberta
Homozygosity of the T allele of the 46 C->T polymorphism in the F12 gene is a risk factor for ischemic stroke in the Spanish population.
Stroke; a journal of cerebral circulation 2004;35(8):1795-9.
2004: Amparo Santamaría; Antonio Martínez-Rubio; Montserrat Borrell; José Mateo; Rosa Ortín; Jordi Fontcuberta
Risk of acute coronary artery disease associated with functional thrombin activatable fibrinolysis inhibitor plasma level.
Haematologica 2004;89(7):880-1.
2004: Amparo Santamaría; Antonio Martínez-Rubio; José Mateo; Isabel Tirado; José Manuel Soria; Jordi Fontcuberta
Homozygosity of the T allele of the 46 C-->T polymorphism in the F12 gene is a risk factor for acute coronary artery disease in the Spanish population.
Haematologica 2004;89(7):878-9.
2004: Alfonso Buil; José Manuel Soria; Juan Carlos Souto; Laura A Almasy; Mark Lathrop; John C Blangero; Jordi Fontcuberta
Protein C levels are regulated by a quantitative trait locus on chromosome 16: results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(7):1321-5.
2004: Jorge Esparza-Gordillo; José Manuel Soria; Alfonso Buil; Laura A Almasy; John C Blangero; Jordi Fontcuberta; Santiago Rodríguez de Córdoba
Genetic and environmental factors influencing the human factor H plasma levels.
Immunogenetics 2004;56(2):77-82.
2004: Isabel Tirado; José Manuel Soria; José Mateo; Arturo Oliver; Juan Carlos Souto; Amparo Santamaria; Rosa Felices; Montserrat Borrell; Jordi Fontcuberta
Association after linkage analysis indicates that homozygosity for the 46C-->T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis.
Thrombosis and haemostasis 2004;91(5):899-904.
2004: Carla Y Vossen; F Eric Preston; Jacqueline Conard; Jordi Fontcuberta; Mike Makris; Felix J M van der Meer; Ingrid Pabinger; Gualtiero Palareti; Inge Scharrer; Juan C Souto; Peter Svensson; Isobel D Walker; Frits R Rosendaal
Hereditary thrombophilia and fetal loss: a prospective follow-up study.
Journal of thrombosis and haemostasis : JTH 2004;2(4):592-6.
2004: Jorge Esparza-Gordillo; José Manuel Soria; Alfonso Buil; Juan Carlos Souto; Laura A Almasy; John C Blangero; Santiago Rodríguez de Córdoba; Jordi Fontcuberta
Genetic correlation between plasma levels of C4BP isoforms containing beta chains and susceptibility to thrombosis.
Journal of medical genetics 2004;41(1):e5.
2003: Juan Carlos Souto; Angel F Remacha; Alfonso Buil; Laura A Almasy; John C Blangero; Jordi Fontcuberta
Genetic determinants of iron metabolism plasma phenotypes and their relationship with risk of thrombosis.
Haematologica 2003;88(12):1436-8.
2003: Rocio Parody; Arturo Oliver; Juan Carlos Souto; Jordi Fontcuberta
Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins.
Haematologica 2003;88(11):ECR32.
2003: Amparo Santamaría; Arturo Oliver; Montserrat Borrell; José Mateo; R Belvis; Joan Martí-Fábregas; Rosa Ortín; Isabel Tirado; Juan Carlos Souto; Jordi Fontcuberta
Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels.
Stroke; a journal of cerebral circulation 2003;34(10):2387-91.
2003: Maria Sabater-Lleal; Elisabeth Martínez-Marchán; Elisabeth Martínez-Sánchez; Mmaculada Coll; Cristina Vallvé; José Mateo; Juan Carlos Souto; Jordi Fontcuberta; José Manuel Soria
Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.
Haematologica 2003;88(8):906-13.
2003: Jorge Esparza-Gordillo; José Manuel Soria; Alfonso Buil; Juan Carlos Souto; Laura A Almasy; John C Blangero; Jordi Fontcuberta; Santiago Rodríguez de Córdoba
Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families.
Immunogenetics 2003;54(12):862-6.
2003: Juan Carlos Souto; Laura A Almasy; José Manuel Soria; Alfonso Buil; William Stone; Mark Lathrop; John C Blangero; Jordi Fontcuberta
Genome-wide linkage analysis of von Willebrand factor plasma levels: results from the GAIT project.
Thrombosis and haemostasis 2003;89(3):468-74.
2003: Amparo Vayá; Yolanda Mira; José Mateo; Cristina Falco; Piedad Villa; Amparo Estelles; Dolores Corella; Jordi Fontcuberta; Justo Aznar
Prothrombin G20210A mutation and oral contraceptive use increase upper-extremity deep vein thrombotic risk.
Thrombosis and haemostasis 2003;89(3):452-7.
2003: Laura A Almasy; José Manuel Soria; Juan Carlos Souto; Immaculada Coll; Delphine Bacq; Alexandra Faure; José Mateo; Montserrat Borrell; Xavier Muñoz; Núria Sala; William H Stone; Mark Lathrop; Jordi Fontcuberta; John C Blangero
A quantitative trait locus influencing free plasma protein S levels on human chromosome 1q: results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) project.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(3):508-11.
2003: Isabel Tirado; Jordi Fontcuberta; José Manuel Soria
Rapid detection of the 46C --> T polymorphism in the factor XII gene, a novel genetic risk factor for thrombosis, by melting peak analysis using fluorescence hybridization probes.
Genetic testing 2003;7(4):295-301.
2003: José Manuel Soria; Laura A Almasy; Juan Carlos Souto; Alfonso Buil; Elisabeth Martinez-Sanchez; José Mateo; Montserrat Borrell; William H Stone; Mark Lathrop; Jordi Fontcuberta; John C Blangero
A new locus on chromosome 18 that influences normal variation in activated protein C resistance phenotype and factor VIII activity and its relation to thrombosis susceptibility.
Blood 2003;101(1):163-7.
2002: Angel F Remacha; Juan Carlos Souto; Elena Rámila; Granada Perea; M Pilar Sarda; Jordi Fontcuberta
Enhanced risk of thrombotic disease in patients with acquired vitamin B12 and/or folate deficiency: role of hyperhomocysteinemia.
Annals of hematology 2002;81(11):616-21.
2002: José Manuel Soria; John C Blangero; Juan Carlos Souto; Elisabeth Martínez-Sánchez; Elisabeth Martínez-Marchán; Immaculada Coll; Isabel Tirado; Albert Cercós; Laura A Almasy; Jordi Fontcuberta
Identification of a large deletion and three novel mutations in exon 13 of the factor V gene in a Spanish family with normal factor V coagulant and anticoagulant properties.
Human genetics 2002;111(1):59-65.
2002: Montserrat Borrell; Dolors Llobet; Rosa Ortín; Rosa Felices; Cristina Vallvé; José Mateo; Juan Carlos Souto; Jordi Fontcuberta
Thromboplastin-thrombomodulin-mediated time: a new global test sensitive to protein S deficiency and increased levels of factors II, V, VII and X.
Haematologica 2002;87(4):415-9.
2002: Eduardo F Tizzano; José Manuel Soria; Immaculada Coll; Blanca Guzmán; Mónica Cornet; Carmen Altisent; Marta Martorell; Montserrat Domenech; Elisabeth del Río; Jordi Fontcuberta; Montserrat Baiget
The prothrombin 20210A allele influences clinical manifestations of hemophilia A in patients with intron 22 inversion and without inhibitors.
Haematologica 2002;87(3):279-85.
2002: José Manuel Soria; Laura A Almasy; Juan Carlos Souto; Delphine Bacq; Alfonso Buil; Alexandra Faure; Elisabeth Martínez-Marchán; José Mateo; Montserrat Borrell; William Stone; Mark Lathrop; Jordi Fontcuberta; John C Blangero
A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease.
American journal of human genetics 2002;70(3):567-74.
2002: Juan Carlos Souto; Laura A Almasy; Montserrat Borrell; William H Stone; Francisco Blanco-Vaca; José Manuel Soria; John C Blangero; Jordi Fontcuberta
Thromboplastin-thrombomodulin-mediated time and serum folate levels are genetically correlated with the risk of thromboembolic disease: results from the GAIT project.
Thrombosis and haemostasis 2002;87(1):68-73.
2001: Isabel Tirado; José Mateo; José Manuel Soria; Arturo Oliver; Montserrat Borrell; Immaculada Coll; Cristina Vallvé; Juan Carlos Souto; Elisabeth Martínez-Sánchez; Jordi Fontcuberta
Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
Haematologica 2001;86(11):1200-8.
2001: Amparo Santamaría; José Mateo; Arturo Oliver; B Menéndez; Juan Carlos Souto; Montserrat Borrell; José Manuel Soria; Isabel Tirado; Jordi Fontcuberta
Risk of thrombosis associated with oral contraceptives of women from 97 families with inherited thrombophilia: high risk of thrombosis in carriers of the G20210A mutation of the prothrombin gene.
Haematologica 2001;86(9):965-71.
2001: Juan Carlos Souto; Laura A Almasy; John C Blangero; William Stone; Montserrat Borrell; Teresa Urrutia; José Mateo; Jordi Fontcuberta
Genetic regulation of plasma levels of vitamin K-dependent proteins involved in hematostatis: results from the GAIT Project. Genetic Analysis of Idiopathic Thrombophilia.
Thrombosis and haemostasis 2001;85(1):88-92.
2000: Amparo Santamaría; José Mateo; Arturo Oliver; Hector Litvan; J Murillo; Juan Carlos Souto; Jordi Fontcuberta
The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Haematologica 2000;85(12):1277-84.
2000: Juan Carlos Souto; Laura A Almasy; Montserrat Borrell; Francisco Blanco-Vaca; José Mateo; José Manuel Soria; Immaculada Coll; Rosa Felices; William Stone; Jordi Fontcuberta; John C Blangero
Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia.
American journal of human genetics 2000;67(6):1452-9.
2000: José Manuel Soria; R Quintana; Cristina Vallvé; G Iruin; C Cortés; Jordi Fontcuberta
A boy with venous thrombosis, homozygous for factor V Leiden, prothrombin G20210A and MTHFR C667t mutations, but belonging to an asymptomatic family.
Haematologica 2000;85(11):1230-2.
2000: Antoni Bayes-Genis; José Mateo; Miquel Santaló; Arturo Oliver; Josep Guindo; Lina Badimon; Antonio Martínez-Rubio; Jordi Fontcuberta; R S Schwartz; Antoni Bayés De Luna
D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain.
American heart journal 2000;140(3):379-84.
2000: Juan Carlos Souto; Laura A Almasy; Eduardo Muñiz-Diaz; José Manuel Soria; Montserrat Borrell; L Bayén; José Mateo; Pedro Madoz; William Stone; John C Blangero; Jordi Fontcuberta
Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(8):2024-8.
2000: José Manuel Soria; Laura A Almasy; Juan Carlos Souto; Isabel Tirado; M Borell; José Mateo; SH Slifer; William Stone; John C Blangero; Jordi Fontcuberta
Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis.
Blood 2000;95(9):2780-5.
2000: Juan Carlos Souto; Laura A Almasy; Montserrat Borrell; M Garí; E Martínez; José Mateo; William H Stone; John C Blangero; Jordi Fontcuberta
Genetic determinants of hemostasis phenotypes in Spanish families.
Circulation 2000;101(13):1546-51.
2000: Amparo Santamaría; José Mateo; E Muñíz-Díaz; Arturo Oliver; J Murillo; Hector Litvan; Juan Carlos Souto; Jordi Fontcuberta
Platelet function during cardiopulmonary bypass not changed by two different doses of aprotinin.
Haematologica 2000;85(4):381-5.
2000: Yolanda Espinosa-Parrilla; M Morell; Montserrat Borrell; Juan Carlos Souto; Jordi Fontcuberta; Xavier Estivill; Núria Sala
Optimization of a simple and rapid single-strand conformation analysis for detection of mutations in the PROS1 gene: identification of seven novel mutations and three novel, apparently neutral, variants.
Human mutation 2000;15(5):463-73.
1999: Juan Carlos Souto; José Mateo; José Manuel Soria; Dolors Llobet; Immaculada Coll; Montserrat Borrell; Jordi Fontcuberta
Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism.
Haematologica 1999;84(7):627-32.
1999: Antoni Bayés-Genís; Josep Guindo; Arturo Oliver; Lina Badimon; Miquel Fiol; José Mateo; Juan Carlos Souto; J M Dominguez; Jordi Fontcuberta; Antoni Bayés de Luna
Elevated levels of plasmin-alpha2 antiplasmin complexes in unstable angina.
Thrombosis and haemostasis 1999;81(6):865-8.
1999: Isabel Tirado; José Mateo; Arturo Oliver; Montserrat Borrell; Juan Carlos Souto; Jordi Fontcuberta
Patients with venous thromboembolism have a lower APC response than controls. Should this be regarded as a continuous risk factor for venous thrombosis?
Haematologica 1999;84(5):470-2.
1999: Maricel Subirà; José Mateo; Juan Carlos Souto; Albert Altés; Jordi Fontcuberta
Lack of association between venous thrombosis and subsequent malignancy in a retrospective cohort study in young patients.
American journal of hematology 1999;60(3):181-4.
1999: Yolanda Espinosa-Parrilla; M Morell; Juan Carlos Souto; Isabel Tirado; Jordi Fontcuberta; Xavier Estivill; Núria Sala
Protein S gene analysis reveals the presence of a cosegregating mutation in most pedigrees with type I but not type III PS deficiency.
Human mutation 1999;14(1):30-9.
1998: Juan Carlos Souto; Immaculada Coll; Dolors Llobet; Elisabeth del Río; Arturo Oliver; José Mateo; Montserrat Borrell; Jordi Fontcuberta
The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population.
Thrombosis and haemostasis 1998;80(3):366-9.
1998: L Falkon; M Garí; M Barbanoj; J Amiral; Jordi Fontcuberta
Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(2):137-41.
1998: L Falkon; M Garí; Ignasi Gich; Jordi Fontcuberta
In-vitro and ex-vivo neutralizing effect of protamine sulphate on the anticoagulant activity of a new low molecular mass heparin.
Thrombosis research 1998;89(2):79-83.
1998: José Mateo; Arturo Oliver; Montserrat Borrell; Núria Sala; Jordi Fontcuberta
Increased risk of venous thrombosis in carriers of natural anticoagulant deficiencies. Results of the family studies of the Spanish Multicenter Study on Thrombophilia (EMET study).
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(1):71-8.
1997: Juan Carlos Souto; Jordi Fontcuberta
[Activated protein C resistance syndrome].
Sangre 1997;42(6):453-66.
1997: P Solves; Albert Altés; Gemma Ginovart; J Demestre; Jordi Fontcuberta
Late hemorrhagic disease of the newborn as a cause of intracerebral bleeding.
Annals of hematology 1997;75(1-2):65-6.
1997: José Mateo; Arturo Oliver; Montserrat Borrell; Núria Sala; Jordi Fontcuberta
Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study).
Thrombosis and haemostasis 1997;77(3):444-51.
1997: A Altès; Juan Carlos Souto; José Mateo; Montserrat Borrell; Jordi Fontcuberta
Activated protein C resistance assay when applied in the general population.
American journal of obstetrics and gynecology 1997;176(2):358-9.
1997: L Falkon; M Bayés; G Frontera; M Garí; M Barbanoj; Jordi Fontcuberta
Pharmacokinetics and tolerability of a new low molecular mass heparin (RO-11) in healthy volunteers--a dose-finding study within the therapeutical range.
Thrombosis and haemostasis 1997;77(1):133-6.